Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients with Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg.

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT04273945
Protocol Number
C-422
Phase
III
Management Group
Pulmonary Critical Care of Atlanta
Disease Sites
Other
Sponsor Protocol
AC-055-315
Principal Investigator
Paul Boyce
Scope
National
Participating Institutions
Pulmonary & Critical Care of Atlanta
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us